02767nas a2200289 4500008004100000245011400041210006900155260001600224300001200240490000700252520179200259653002402051653002602075653001602101653001702117653003102134100002702165700003002192700003502222700002502257700002602282700002902308700003202337700003202369700001402401856006202415 2020 eng d00aTrypanocidal Potentialities of Skimmianine an Alkaloid Isolated from Zanthoxylum pistaciifolium Griseb Leaves0 aTrypanocidal Potentialities of Skimmianine an Alkaloid Isolated  cAugust 2020 a322-3270 v123 a

Background: Zanthoxylum pistaciifolium Griseb (Rutaceae) is an endemic Cuban species traditionally used for respiratory ailment treatments and religious practices. Objective: The aim of this study was to evaluate the in vitro antimicrobial activity from Z. pistaciifolium leaves. Materials and Methods: Four phases obtained from the ethanolic extract were tested against bacteria (Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa), fungi (six Candida spp.) and parasites (Leishmania amazonensis and Trypanosoma cruzi) by microdilution methods. In addition, the cytotoxicity was determined against peritoneal macrophages from BALB/c mice and fibroblast cells L929 using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and resazurin assay. Results: The hexane-butanone phase was the most active against Candida spp. and exhibited moderate effect on T. cruzi trypomastigote (39.3 ± 5.5 μg/mL). The skimmianine isolated from this phase and characterized by nuclear magnetic resonance showed a median inhibitory concentration of 58.0 ± 4.0 μg/mL against T. cruzi trypomastigotes and 31.2% ± 6.5% of inhibition on amastigote form at 100 μg/mL. Antiprotozoal activity of this alkaloid was selective with a selectivity index of 9. Conclusion: The current study demonstrated for the first time the antimicrobial potential of the leaves of Z. pistaciifolium, supporting its ethnobotanical uses. The trypanocidal activity observed for the alkaloid skimmianine could contribute to development future of an herbal medicine for the treatment of Chagas diseases.

10aAntifungal activity10aHexane-butanone phase10aSkimmianine10aTrypanocidal10aZanthoxylum pistaciifolium1 aDiaz, Yamilé, Heredia1 aArranz, Julio, César Esc1 aFernández, Rosalia, González1 aPacheco, Ania, Ochoa1 aDíaz, Jesus, García1 aFidalgo, Lianet, Monzote1 aBatista, Denise, da Gama Ja1 ada Silva, Cristiane, Franca1 aCos, Paul uhttps://www.phcogres.com/article/2020/12/3/104103prpr4419